Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma. (March 2022)
- Record Type:
- Journal Article
- Title:
- Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma. (March 2022)
- Main Title:
- Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma
- Authors:
- Pádua, Joel Del Bel
Mariano, Carolline Fontes Alves
Fabro, Alexandre Todorovic
Tirapelli, Daniela Pretti da Cunha
Sankarankutty, Ajith Kumar
dos Santos, José Sebastião
Brunaldi, Mariângela Ottoboni - Abstract:
- Current scientific literature lacks data on the prognostic value of the expression of RAD51 and BRCA2 in gastric adenocarcinoma. Therefore, we aimed to evaluate those and other homologous recombination-related proteins (ATM, ATR, BRCA1, CHK2, γH2AX, p53) in gastric cancer, assessing their correlation with clinical prognosis. Paraffin-embedded samples were obtained from surgical specimens collected in total or subtotal gastrectomy procedures. Between 2008 and 2017, 121 patients with advanced gastric adenocarcinoma underwent surgical resection and were included in this study. Negativity for nuclear RAD51 correlated with vascular invasion, lymph node metastasis, larger tumor size, and lower overall survival and disease-free survival in univariate analysis. However, nuclear RAD51-negative cases presented better response rates to adjuvant therapy than the positive ones. Nuclear ATR negativity correlated with larger tumor size and a higher histological grade. Positivity for ATM was associated with more prolonged disease-free survival. Positivity for nuclear BRCA2 correlated with lower overall survival and diffuse histological type, whereas its high expression was associated with vascular invasion. Nevertheless, tumors positive for nuclear BRCA2 were more frequently low grade in the intestinal histological type. Our findings indicate that RAD51 and BRCA2 are valuable immunohistochemical prognostic markers in gastric adenocarcinoma.
- Is Part Of:
- Journal of histochemistry and cytochemistry. Volume 70:Number 3(2022)
- Journal:
- Journal of histochemistry and cytochemistry
- Issue:
- Volume 70:Number 3(2022)
- Issue Display:
- Volume 70, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 70
- Issue:
- 3
- Issue Sort Value:
- 2022-0070-0003-0000
- Page Start:
- 199
- Page End:
- 210
- Publication Date:
- 2022-03
- Subjects:
- DNA repair -- homologous recombination -- immunohistochemistry -- stomach neoplasms
Histochemistry -- Periodicals
Cytochemistry -- Periodicals
Histocytochemistry -- methods
Histological Techniques
572.05 - Journal URLs:
- http://www.jhc.org/ ↗
http://journals.sagepub.com/home/jhc ↗
http://www.sagepublications.com/ ↗ - DOI:
- 10.1369/00221554211065834 ↗
- Languages:
- English
- ISSNs:
- 0022-1554
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19283.xml